Ascendis Pharma A/S (ASND)

220.42 +10.26 (+4.88%) USD  |  NASDAQ  |  Dec 12, 16:00
220.58 +0.16 (+0.07%) After-Hours: 20:00
More

Ascendis Pharma EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Evaxion AS --
Novo Nordisk A/S Upgrade
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --